About this document
Antibiotic Commercialization Under Stewardship by boatpvt05 is a document available to read on EtoBox.
NovaCure is developing a commercialization model for NC-47 that adheres to stewardship guidelines while ensuring sustainable revenue. The proposed approach includes a phased hybrid model targeting private tertiary hospitals first, followed by public institutions, and incorporates innovative pricing mechanisms like subscription models and outcome-based pricing. Additionally, the strategy considers the influence of public tenders and pricing controls on market adoption and revenue generation.
- Author
- boatpvt05
- Language
- EN